BAL-3833

N/A

Report date: 2023/07/01 20:00:34
NME

Base Information

Drug NameBAL-3833
Drug Alias NameCCT-3833BAL-3833BAL3833 (CCT3833)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase B-raf inhibitorsC-Raf kinase inhibitorsSRC inhibitors
TargetsSerine/threonine-protein kinase B-rafC-Raf kinaseSRC
Therapy Area/IndicationsMelanomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBasilea Pharmaceutica
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBasilea PharmaceuticaThe Institute Of Cancer Research, London
Active IndicationsN/A
Inactive IndicationsMelanomaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A